Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (2016 - 2022)

Corbus Pharmaceuticals Holdings has reported Capital Expenditures over the past 8 years, most recently at $13449.0 for Q1 2022.

  • For Q1 2022, Capital Expenditures changed N/A year-over-year to $13449.0; the TTM value through Dec 2022 reached $13449.0, down 82.08%, while the annual FY2022 figure was $13449.0, 75.17% down from the prior year.
  • Capital Expenditures for Q1 2022 was $13449.0 at Corbus Pharmaceuticals Holdings, down from $54172.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.3 million in Q4 2019 and troughed at -$1.2 million in Q2 2018.
  • A 5-year average of $235415.8 and a median of $57173.0 in 2018 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 3063.92% in 2018 and fell as far as 3061.65% in 2018.
  • Year by year, Capital Expenditures stood at -$91528.0 in 2018, then skyrocketed by 1511.01% to $1.3 million in 2019, then crashed by 104.03% to -$52086.0 in 2020, then surged by 204.0% to $54172.0 in 2021, then tumbled by 75.17% to $13449.0 in 2022.
  • Business Quant data shows Capital Expenditures for CRBP at $13449.0 in Q1 2022, $54172.0 in Q4 2021, and -$52086.0 in Q4 2020.